One Nucleus Summer Life Sciences Dinner, Wednesday 6 July 2022
On the eve of our annual ON Helix Conference, we were pleased to welcome over 100 guests to attend the inaugural One Nucleus Summer Life Sciences Dinner on the stunning grounds of Babraham Research Campus.
The evening began with a networking drinks reception and once seated, Tony Jones, CEO, One Nucleus thanked the sponsors and guests for attending and supporting the evening.
In between courses, names were pulled out of a hat and six lucky winners received a copy of the book, ‘Cambridge per diem’ by Rosie Zanders. In this book,…
Link below to EY blog by Pamela Spence (EY PArtner)
https://www.linkedin.com/pulse/how-you-prioritize-your-supply-chain-inv…
Invited guests enjoyed a look around Nottingham CRO Cellomatics Biosciences’ new lab facilities at Colwick Quays Business Park last week, at a special launch event hosted by the company’s CEO and founder, Dr Shailendra Singh.
Cellomatics moved into the purpose-built premises last month in the wake of rising demand for its bespoke preclinical and early drug discovery phase laboratory services. Representing a three-fold increase in the company’s footprint, the facility covers approximately 5,500 sq ft of space across two levels and allows rooms for further expansion.
Members of the drug…
AMSBIO has expanded its range of antibodies, biomarkers and assay kits related to free radicals (ROS and RNS), non-radical reactive derivatives (or oxidants) and antioxidants for researchers investigating the mechanism of oxidative stress.
It is widely recognized free radicals play a key role in physiological processes including protein phosphorylation as well as activation of transcriptional factors and immunity, but they need to be kept at a low level.
Changes in environmental factors, diet and lifestyle are known to contribute significantly to an increase in free radical production in the…
State-of-the-art laboratories significantly expand project capacity to meet increasing market demand for Organ-on-a-Chip research services
Cambridge, UK, 19 July 2022: CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the opening of new laboratory facilities at Cambridge Science Park, dedicated to its contract research services. The Company’s laboratory space has been doubled in response to the increasing market demand for OOC services as the technology gains traction within drug…
Press release - Appointments
Macomics Announces New Hires as it Expands its Macrophage-based Drug Discovery and Operations Teams
Edinburgh and Cambridge, UK, 18 July 2022 - Macomics Ltd, an immuno-oncology company with world-leading expertise in macrophage biology, announces today that it has made three new appointments to its scientific and operations teams, to support growth and accelerate its R&D.
In the R&D team, Dr Thomas Crozier joins as a Senior Scientist and Dr Yuxin Cui joins as Senior Bioinformatician, with Ms. Lisa Seymour joining as Operations Manager and Health &…
A screening tool developed in research led at the University of Strathclyde, UK could increase the number of tests on a solid tumour sample by up to 50 times.
The tool is designed for testing at scale the latest immunotherapies, such as Chimeric Antigen Receptor (CAR) T-cell therapy, which is effective against many haematological cancers but presents challenges when used to treat solid tumours.
Traditional 2D models that are currently used fail to reproduce the complexity of the tumour’s microenvironment, while models based on patients’ tumours are costly and labour-intensive. The Strathclyde…
Past, Present and (Possible) Future of CAR-T Cell Therapy Usefully Reviewed by One Nucleus Partners BioIVT
AI-powered drug discovery company Healx opens new labs at Chesterford Research Park
The biotech company secures Suite 3 & 4 in the Science Village
Cambridge, UK, 12th July 2022: Chesterford Research Park is delighted to welcome Healx to the Park’s prestigious Science Village.
Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery for rare diseases, is taking more than 3,500 sq ft of space within the Park’s multi-occupancy lab building.
The Science Village is home to both established…
A city centre building tailored to the commercialisation of life sciences has reached full capacity. The Biosphere opened its doors just three years ago, and is now home to more than 20 businesses, forming a vibrant and innovative life science cluster on Newcastle Helix.
This fit-for-purpose laboratory and office building is dedicated to life science research, development, and commercialisation. It has become a global hub for innovation, with businesses who are based there working on solutions for some of society’s most pressing global challenges, such as COVID-19, cancer, and climate change…